Silence Therapeutics SLN
NASDAQ SLN
$19.67 +0.06 (+0.31%)
At close: Oct 21, 2026 · 4:00 PM EDT

Silence Therapeutics (SLN) Restructuring Costs (2025)

Updated

Silence Therapeutics (SLN) reported Restructuring Costs of $1.32 million for the year ended Dec 31, 2025.

Analysis

Silence Therapeutics (SLN) Restructuring Costs (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Silence Therapeutics 927.96 Mn 855.86 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 1.32 Mn
API Access

Silence Therapeutics Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=SLN&period=max&api_key=YOUR_API_KEY